Genovis AB

Genovis AB Series B
Stock Exchange First North Sweden
EPS
SEK0.1
Market Cap
SEK371.03 M
Shares Outstanding
63.1 M
Public Float
-

Profile

Address
Scheelevägen 2
Lund SN 220 07
Sweden
Employees -
Website http://www.genovis.com
Updated 09/14/2018
Genovis AB engages in the development and market of nanotechnology. It develops, produces and markets technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.

Financials

View All

Mårten Winge
Chairman
Lena Carina Söderström
Director